CJ CheilJedang, T&R Biofab team up for alternative meat

South Korean food and bio giant CJ CheilJedang Corp. is harnessing advanced innovative technology to secure sustainable future food resources.

The company announced on Wednesday that it has signed a joint development agreement with T&R Biofab, a South Korean biomedical engineering company, utilizing 3D bioprinting technology to create alternative meat.

T&R Biofab possesses world-class technology in the field of regenerative medicine based on 3D bioprinting, which is used to develop artificial tissues. The collaboration aims to develop alternative meat that surpasses the limitations of conventional plant-based foods in terms of taste, texture, appearance and nutrition.

According to market research firm Bloomberg Intelligence, the plant-based food market is expected to grow from $24.9 billion in 2020 to $162 billion in 2030. Achieving the taste and nutritional qualities of animal-based foods in plant-based alternatives remains a challenge.

CJ CheilJedang continues to invest in technology development for securing sustainable future food resources. It has launched the plant-based food brand PlanTable, selling plant-based dumpling products domestically and internationally, and introduced the plant-based beverage brand Altive through an in-house startup program.

Write to Kyeong-je Han at hankyung@hankyung.com